GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

The 2026 U.S. cholesterol guidelines urge starting screening and treatment at 30 to prevent cardiovascular disease effectively.

A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered hypertension and prevented serious disease or death for thousands of ...

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...

American College of Cardiology (ACC), and nine other leading medical organizations have released updated guidelines for ...

Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, applauded the recommendation that the treatment of CV risk in ...

Freeman Heart & Vascular Institute has earned Level 1 STEMI designation from the Missouri Department of Health and Senior Services. Freeman Health System previously received Level 1 honors in 2017, ...

The American Heart Association (AHA) and the American College of Cardiology (ACC) have recently released the first guideline ...

Because of their hormones and anatomy, women don’t experience heart disease the same way men do. Here’s what sets women’s heart health apart and why it matters.

Increasing Prevalence of Acute Coronary Syndrome, Expanding Post-PCI Treatment Protocols, and Growing Healthcare Infrastructure in Emerging Economies Drive Market Growth.Austin, March 16, 2026 (GLOBE ...

MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in ...

A recent retrospective study found that performing Chronic Total Occlusion Percutaneous Coronary Intervention (CTO-PCI) ...